Sensulin, LLC
http://www.sensulin.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sensulin, LLC
Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks
The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.
Start-Up Previews, November 2013
This Month's Profile Group: Heightened Concussion Awareness Calls For New Detection Tools, features profiles of Cerora, MC10, Oculogica, and Sway Medical. Plus these Start-Ups Across Health Care: Bicycle Therapeutics, Crosstrees Medical, Rescue Therapeutics, and Sensulin.
Sensulin LLC
Sensulin LLC aims to treat diabetes by linking a liposome-encapsulated form of recombinant human insulin with a boronic-acid derivative that is a competitive binder with glucose. If the drug works as envisioned, it would reduce the risk of hypoglycemia that can occur when glucose levels fluctuate during the day, and would also obviate the need for multiple injections and constant monitoring.
Start-Up Execs On The Move, September 2013
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
In Vitro Diagnostics
- Glucose Testing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice